Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.

Miura, H; Takada, M; Fujiwara, M; Fujiwara, S

Miura, H; Takada, M; Fujiwara, M; Fujiwara, S.

Affiliation

Miura H; Department of Dermatology, Osaka Minato Central Hospital, Osaka, Japan.
Takada M; Department of Dermatology, Osaka Minato Central Hospital, Osaka, Japan.
Fujiwara M; Department of Dermatology, Osaka Minato Central Hospital, Osaka, Japan.
Fujiwara S; Department of Dermatology, Osaka Minato Central Hospital, Osaka, Japan.

Br J Dermatol ; 184(2): e30, 2021 02.

Article in En | MEDLINE | ID: mdl-32845515

Subject(s)

Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Skin Neoplasms; Administration, Topical; Aminoquinolines/therapeutic use; Antineoplastic Agents/therapeutic use; Carcinoma, Basal Cell/drug therapy; Carcinoma, Merkel Cell/drug therapy; Humans; Imiquimod/therapeutic use; Skin Neoplasms/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Carcinoma, Merkel Cell / Antineoplastic Agents Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google